MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for its landmark knee osteoarthritis...
Search results for "FDA approval"
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio
Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology designed to deliver potent anticancer...
Celltrion Secures Historic FDA Interchangeability Status for Truxima
Celltrion announced on the 1st that the U.S. Food and Drug Administration has granted interchangeable status to Truxima...
FDA Grants Streamlined Path for MediPost’s Cartistem, Slashing U.S. Trial Burden
The U.S. Food and Drug Administration has agreed to a significantly streamlined clinical path for Cartistem, a landmark...
Expanded Health Insurance Coverage Lowers Barrier to Care for Rare Heart and Kidney Disorder
Patients suffering from light-chain amyloidosis, a rare and debilitating blood disorder that causes abnormal proteins...
South Korean Biotechs Race to Conquer the Untapped Global MASH Market
Fat accumulation in the liver can trigger severe inflammation even in individuals who completely abstain from alcohol.
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?
A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World...
YuhanUSA and Huinno Partner to Launch AI-Powered ECG Monitoring in the U.S.
YuhanUSA, the U.S. subsidiary of Yuhan Corporation, announced on the 30th that it has signed a strategic business...
Alteogen Secures U.S. Patent Registration for Keytruda SC Formulation
Alteogen announced on the 12th that it has secured registration with the United States Patent and Trademark Office for...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...